Rhythm Pharmaceuticals Inc (RYTM) — Net Asset Quality Index
Rhythm Pharmaceuticals Inc (RYTM) has a Net Asset Quality Index of 28.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $481.19 Million minus total liabilities of $342.12 Million yields net assets of $139.07 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Rhythm Pharmaceuticals Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Rhythm Pharmaceuticals Inc Net Asset Quality Index Over Time (2012–2025)
This chart shows how Rhythm Pharmaceuticals Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 28.9%, representing net assets of $139.07 Million against total assets of $481.19 Million USD. See RYTM net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Rhythm Pharmaceuticals Inc (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Rhythm Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Rhythm Pharmaceuticals Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 28.9% | $139.07 Million | $481.19 Million | $342.12 Million | ▼ -13.0 pp |
| 2024 | 41.9% | $164.55 Million | $392.27 Million | $227.72 Million | ▼ -9.1 pp |
| 2023 | 51.0% | $169.76 Million | $332.75 Million | $162.99 Million | ▼ -18.1 pp |
| 2022 | 69.1% | $264.26 Million | $382.48 Million | $118.22 Million | ▼ -17.1 pp |
| 2021 | 86.2% | $284.15 Million | $329.52 Million | $45.37 Million | ▼ -2.8 pp |
| 2020 | 89.0% | $166.53 Million | $187.07 Million | $20.55 Million | ▼ -2.1 pp |
| 2019 | 91.1% | $281.02 Million | $308.52 Million | $27.50 Million | ▼ -3.6 pp |
| 2018 | 94.6% | $246.26 Million | $260.21 Million | $13.95 Million | ▼ -0.8 pp |
| 2017 | 95.4% | $144.79 Million | $151.74 Million | $6.95 Million | ▲ +36.3 pp |
| 2016 | 59.1% | $7.30 Million | $12.34 Million | $5.04 Million | ▼ -26.7 pp |
| 2015 | 85.9% | $32.00 Million | $37.27 Million | $5.27 Million | ▲ +270.4 pp |
| 2014 | -184.5% | $-358.00K | $194.00K | $552.00K | ▲ +131.4 pp |
| 2013 | -316.0% | $-57.46 Million | $18.19 Million | $75.65 Million | ▼ -124.2 pp |
| 2012 | -191.8% | $-36.28 Million | $18.92 Million | $55.21 Million | — |